BioSpace News Archive

Valent BioSciences Introduces MetaLarv ® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats

Konica Minolta Healthcare Americas, Inc. and nVoq Incorporated announce an agreement to embed nVoq’s cloud-based speech recognition and automation solution in the Exa® Platform.

Genmab Interim Report for the First Quarter Ended March 31,2021

Isosceles Pharmaceuticals Inc. today announced the appointment of William D. Humphries as its Chief Executive Officer.

A peer-reviewed journal has published the first research paper to state that the PrecivityAD™ blood test “can accurately identify brain amyloid status based on a single blood sample.”

The International Foundation for Research and Education on Depression Introduces a 10-Day Challenge Dedicated to Teaching and Learning Hope

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced that results from the lenzilumab Phase 3 study in hospitalized COVID-19 patients (referred to as ‘LIVE-AIR’) were published online at link .

The number of Units to be distributed under the Offering, the price of each Unit and the exercise price of each Warrant will be determined in the context of the market.

James Lanthier, CEO of Mindset, commented, “Mindset is pleased to be invited to present at Canaccord Genuity’s Growth Conference.

“We are thrilled to be up-listing on to the OTCQB, which will allow for greater engagement with our U.S. investor base.